Trial intelligence / Profile preview

Phase II toripalimab plus capecitabine maintenance after curative treatment in high-risk locally advanced head and neck squamous cell carcinoma

ChiCTR2400090080Phase 2Recruiting

Sponsor

Tumor Hospital Affiliated to Guizhou Medical University

Start

Sep 2024

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1